Across TCGA pan-cancer cohorts, RPL36AP29 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL36AP29’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RPL36AP29 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL36AP29 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KICH, HNSC, and LIHC are the cancer types where RPL36AP29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL36AP29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	III,IV	−0.312	<.001	6	view →
HNSC	All	II,III,IV	+0.139	.002	5	view →
LIHC	Male	III,IV	+0.220	.002	2	view →
THCA	Female	All	−0.111	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPL36AP29 RNA expression & survival · all RPL36AP29 data types